Robotic-assisted retroperitoneal lymph node dissection: defining selection parameters-a B-SAFE approach
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Robotic retroperitoneal lymph node dissection (RRPLND) is safe and effective for testicular cancer, with the
Area Of Science
- Urology
- Surgical Oncology
- Minimally Invasive Surgery
Background
- Retroperitoneal lymph node dissection (RPLND) is a critical component in the management of testicular cancer.
- Robotic RPLND (RRPLND) offers potential advantages in precision and recovery.
- Standardized selection criteria are essential for optimizing RRPLND outcomes.
Purpose Of The Study
- To define selection parameters for RRPLND using the 'B-SAFE' system.
- To evaluate the oncological and peri-operative outcomes of RRPLND based on these criteria.
- To compare RRPLND outcomes with traditional open RPLND.
Main Methods
- Retrospective analysis of 57 patients undergoing RRPLND (2017-2023).
- Application of the 'B-SAFE' criteria for robotic case selection.
- Comparison with a cohort of 57 patients undergoing open RPLND.
Main Results
- No open conversions were required in the RRPLND group.
- RRPLND demonstrated a shorter length of stay (2 vs 6 days) and reduced blood loss (130 vs 865 mL) compared to open RPLND.
- Similar oncological outcomes (positive margin rates) and complication rates were observed between RRPLND and open RPLND, with higher nodal yield in RRPLND.
Conclusions
- The 'B-SAFE' system provides effective parameters for selecting appropriate cases for RRPLND.
- RRPLND achieves excellent short-term oncological outcomes with minimal peri-operative morbidity and a short length of stay.
- Increasing experience allows for the expansion of selection criteria to include more complex cases.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.